Abstract OBJECTIVES: Ischaemic heart disease is the leading cause of death in the elderly population. Coronary artery bypass graft (CABG) surgery via sternotomy remains the standard of care for patients with multivessel coronary artery disease (CAD). Minimally invasive cardiac surgery (MICS)-CABG via left thoracotomy has been used as an alternative to sternotomy. The aim of our study was to assess the overall survival after MICS-CABG and sternotomy-CABG in elderly patients with CAD.
INTRODUCTION
The elderly population represents a wide sector in the USA, which has a high prevalence of significant triple-vessel coronary artery disease (CAD) [1, 2] . These patients have a better outcome and lower mortality with cardiac revascularization procedures compared with non-revascularization [3] [4] [5] . Although they have a higher risk of early morbidity and mortality, studies show that elderly patients with multivessel CAD have better survival with coronary artery bypass grafting (CABG) than percutaneous coronary artery angioplasty [6, 7] .
For four decades, CABG via sternotomy has been the gold standard for coronary revascularization in multivessel CAD. Recently non-sternotomy approaches, including the minimally invasive cardiac surgery CABG (MICS-CABG) via a small left thoracotomy, have emerged as safe and effective alternatives [8] [9] [10] [11] . MICS-CABG is performed via left thoracotomy using a 6-to 7-cm incision with a significant reduction in chest trauma, better cosmesis, less postoperative pain, early recovery and short hospital stay [12, 13] . However, the durability of this approach and its impact on long-term survival have yet to be confirmed. The goal of this study is to compare the long-term outcome after MICS-CABG and sternotomy-CABG in elderly patients (75 years and older) with CAD.
METHODS
We identified 1126 patients who presented for coronary bypass surgery at Staten Island University Hospital in Staten Island, New York, between January 2005 and December 2008. Those undergoing concomitant valve surgery were excluded. Only patients older than and equal to 75 years (n = 159) of age were included in the final analysis. The patients were divided into two groups: MICS-CABG and sternotomy-CABG. We also compared outcomes of MICS-CABG with sternotomy-CABG in the less than 75-year-old population in order to provide a comparison for the 75 years and older subgroup. All patients were followed until January 2012. The primary outcome was all-cause mortality.
After institutional review board approval, trained physicians using our hospital medical records retrieved demographic data, coronary artery risk factors, comorbidities, laboratory values, left ventricular ejection fraction, New York Heart Association, Canadian Cardiovascular Society class and procedural information of each index case. Survival status was retrieved from our medical records and social security death index.
Surgical technique
MICS-CABG is performed via antero-lateral thoracotomy with a 6-to 7-cm incision in the left fifth intercostal space, started at ADULT CARDIAC E.A. Barsoum et al. / European Journal of Cardio-Thoracic Surgerythe midclavicular line and extended laterally. The left internal mammary artery (LIMA) is skeletonized under direct vision using long instruments. The pericardium is opened parallel and anterior to the left phrenic nerve from the left atrial appendage towards the diaphragmatic reflection. Meanwhile, saphenous venous grafts are harvested endoscopically or open by a trained surgical physician assistant. Proximal anastomosis is facilitated by bringing the ascending aorta closer to the thoracotomy wound using the following techniques: depressing pulmonary trunk by an epicardial stabilizer inserted via a 6-mm of the seventh intercosal space, hyperinflation of the isolated right lung and anterior retraction of the aorta by open gauze inserted between the pulmonary trunk and the ascending aorta [8] . For distal anastomoses, a Starfish NS (Medtronic, Minneapolis, MN, USA) apical positioner was inserted via a 1-cm subxiphoid incision and suction was applied onto the apex of the heart. Retraction of the cardiac apex towards the patient's left shoulder and the right hip allows visualization of the posterior descending artery and the circumflex coronary artery marginal branches, respectively. For each distal anastomosis, the Octopus NS (Medtronic) epicardial tissue stabilizer is positioned along the targeted segment, and a silicone elastomer occluder is placed around the grafted coronary artery segment. Coronary anastomosis is performed by using running 7-0 polypropylene. At the end of the procedure, all grafts are inspected under direct vision to rule out kinking or tension. In patients requiring cardiopulmonary bypass, a femoral or subclavian approach is utilized [8] .
Statistical analysis
Baseline characteristics of patients were compared using the χ 2 test for categorical variables and the independent sample t-test for continuous variables. The distributions of continuous and categorical variables were represented as means ± standard deviations, and frequencies and percentages, respectively. A univariate screen of all potential predictors of all-cause mortality using a Cox proportional hazard model for each variable was performed. Those variables that had a P-value of <0.1 or those clinically relevant were considered as potential predictors. To evaluate the impact effect of MICS-CABG versus sternotomy-CABG on overall survival, other confounding variables were included one by one to the primary variable (MICS versus sternotomy) in bivariate Cox proportional hazard models. Furthermore, a multivariate Cox regression was performed to explain the association between mortality and several independent variables deemed either to have significant association with mortality at the bivariate level or to be considered as clinically important. In the initial multivariate model, all potential predictors were included, along with MICS-CABG as an independent variable. Subsequently, backward regression was performed to include only those variables with P < 0.05 in the final multivariate model. Kaplan-Meier curves were constructed, and the study groups were compared with use of the log-rank test.
Hazard ratios and 95% confidence intervals derived from the Cox proportional hazard model are provided for the primary outcome. All statistical analyses were performed with the use of STATA version 11.0, College Station, TX, USA.
RESULTS
The patients of age 75 years and older (n = 159) had a mean age 79. , P = 0.018), but the sternotomy-CABG group had a significantly higher total number of grafts (sternotomy 3.22 ± 0.93/MICS 2.26 ± 0.73; P < 0.001).
The follow-up period was 3.7 ± 1.5 years. Patients under 75 years of age had no significant difference in mortality between MICS and sternotomy groups (P = 0.90). With regard to patients 75 years and older, at the end of the study period, 50 (47.6%) died in the sternotomy-CABG group, compared with only 12 (19.7%) in the MICS-CABG group (P < 0.001). In addition, the Kaplan-Meier curve showed significantly higher overall survival in the MICS-CABG group compared with the sternotomy-CABG group, with log-rank P = 0.016 (Figs 1 and 2 ).
MICS-CABG and the other predictors of mortality
Patients 75 years and older with a history of heart failure, elevated preoperative creatinine and history of prior percutaneous ADULT CARDIAC E.A. Barsoum et al. / European Journal of Cardio-Thoracic Surgerycoronary intervention (PCI) were significant predictors of higher mortality in the univariate screening models. Each of the potential confounders was individually analysed with the surgical approach in a bivariate model (Table 2) . We found that MICS-CABG was a significant predictor of better outcome (with an adjusted HR ranging from 0.40 to 0.50) in the presence of other confounding variables (age, gender male, body mass index, smoker, hypertension, history of myocardial infarction, history of prior PCI, history of prior CABG, history of prior heart failure, diabetes mellitus, preoperative creatinine, cardiopulmonary bypass, number of grafts and internal mammary artery utilization) with P-values of <0.05 (Table 3) . By using a multivariate Cox regression model for all-cause mortality among elderly patients, age, preoperative creatinine and history of prior PCI were predictors of higher mortality. Compared with sternotomy-CABG, MICS-CABG had an adjusted hazard ratio 0.51 (95% confidence interval 0.26-0.97; P = 0.04; Table 4 ).
DISCUSSION
In our study, we found patients 75 years and older to have a significantly lower 5-year all-cause mortality with MICS-CABG compared with sternotomy-CABG. This finding was not solely explained by a higher short-term mortality, as MICS-CABG continued to have a better survival over the 5-year follow-up period according to the Kaplan-Meier curve. Moreover, this better survival in the MICS-CABG group remained after adjusting for other confounders. This finding was not observed among the younger group ( patients less than 75 years old) who had no significant difference in mortality between MICS-CABG and sternotomy-CABG. Different techniques have been used to make CABG less invasive in elderly patients including off-pump coronary artery bypass grafting (OPCAB) and minimally invasive direct coronary artery bypass (MIDCAB). Although OPCAB has better short-term results in the elderly [14] [15] [16] [17] , Li et al. [18] reported a worse long-term result in patients over 65 with OPCAB. In our study, MICS demonstrated better long-term survival in the elderly regardless of the use of cardiopulmonary bypass. Fraund et al. [19] reported that MIDCAB produced a significant reduction in 30-day mortality in patients older than 70 compared with conventional CABG. There are no studies comparing long-term outcome between MIDCAB and conventional CABG in elderly populations. Our study suggests a long-term benefit from MICS-CABG to this group of patients.
Impact of the number and type of coronary artery bypass grafts on survival in the elderly
In an observational study including 500 octogenarians, Kozower et al. [20] demonstrated that complete revascularization in the elderly yields better long-term survival than incomplete revascularization. However, in a recent study of 6539 patients, Girerd et al. [21] demonstrated that the survival benefit of complete revascularization was noted only in patients younger than 60 years. In our study, the number of grafts was less in MICS-CABG compared with the number of grafts in sternotomy-CABG, but survival was better with MICS-CABG.
Previous studies demonstrated better survival in elderly patients undergoing LIMA grafting [22] [23] [24] . In our study, the greater rate of LIMA graft use was in the MICS-CABG group (98.4% of patients). Bivariate analysis of the effect of MICS-CABG on survival was independent of LIMA utilization. As most of our MICS-CABG patients had LIMA grafting, we could not evaluate the effect of LIMA on the elderly. We suggest that most of the survival benefit in the elderly population undergoing CABG is attributable to the use of the LIMA rather than the total number of grafts.
Study limitations
The main limitation of this study is its retrospective nature in a single centre. The number of cases was small to adjust for all predictors in one multivariate model. There is a possibility of missing a number of outcomes by using the social security death index and medical records to assess mortality. There is a possibility of residual confounding due to several unaccounted differences between MICS-CABG and sternotomy-CABG groups (prior MI, LIMA use and heart failure). Also our study explored all-cause mortality without other known major adverse cardiovascular events.
Conclusion
In the elderly subgroup of severe CAD, minimally invasive coronary artery bypass surgery is a safe and effective alternative to sternotomy-CABG. Despite our relatively small number of patients and different baseline characteristics, we have noted better longterm survival among MICS-CABG patients 75 years and older compared with the sternotomy-CABG group. This may be attributable to potential confounders, and further prospective studies and randomized controlled trials are needed to validate our findings. 
